Omega Healthcare Investors Proxy Statement Supplement Filed

TL;DR

OHI filed proxy supplement for June 6th annual meeting. Vote your shares!

AI Summary

Omega Healthcare Investors, Inc. (OHI) filed a Definitive Proxy Statement (DEFA14A) on May 21, 2025, supplementing materials for its Annual Meeting of Stockholders scheduled for June 6, 2025. The filing provides additional information to shareholders regarding the upcoming meeting and voting matters.

Why It Matters

This filing provides shareholders with updated information before the annual meeting, ensuring they have the necessary details to make informed voting decisions on corporate matters.

Risk Assessment

Risk Level: low — This is a routine proxy filing providing supplemental information for an upcoming shareholder meeting, not indicating any unusual risks.

Key Players & Entities

• Omega Healthcare Investors, Inc. (company) — Registrant
• 0001104659-25-051308 (filing_id) — Accession Number
• June 6, 2025 (date) — Annual Meeting Date
• May 21, 2025 (date) — Filing Date

FAQ

From the Filing

0001104659-25-051308.txt : 20250521 0001104659-25-051308.hdr.sgml : 20250521 20250521080017 ACCESSION NUMBER: 0001104659-25-051308 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20250521 DATE AS OF CHANGE: 20250521 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMEGA HEALTHCARE INVESTORS INC CENTRAL INDEX KEY: 0000888491 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] ORGANIZATION NAME: 05 Real Estate & Construction EIN: 383041398 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-11316 FILM NUMBER: 25970924 BUSINESS ADDRESS: STREET 1: 303 INTERNATIONAL CIRCLE, STREET 2: SUITE 200 CITY: HUNT VALLEY STATE: MD ZIP: 21030 BUSINESS PHONE: 410-427-1700 MAIL ADDRESS: STREET 1: 303 INTERNATIONAL CIRCLE, STREET 2: SUITE 200 CITY: HUNT VALLEY STATE: MD ZIP: 21030 DEFA14A 1 tm2515618d1_defa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy Statement x Definitive Additional Materials ¨ Soliciting Material Pursuant to § 240.14a-12 Omega Healthcare Investors, Inc. (Name of Registrant as Specified in Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): x No fee required. ¨ Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11 ¨ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 SUPPLEMENT TO PROXY STATEMENT RELATED TO ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON JUNE 6, 2025 This Supplement, dated May 21, 2025, supplements the definitive Proxy Statement of Omega Healthcare Investors, Inc. (the "Company," “Omega,” "we," "us," "our" and similar terms), dated April 22, 2025, and is furnished to the Company's stockholders in connection with the solicitation of proxies on behalf of the Board of Directors of the Company for the Company's 2025 Annual Meeting of Stockholders to be held on June 6, 2025, or any adjournment or postponement thereof. This Supplement is being filed with the Securities and Exchange Commission and is first being made available to the Company's stockholders on or about May 21, 2025. Except to the extent described in this Supplement, none of the items or information contained in the Proxy Statement are affected by this Supplement. This Supplement does not provide all of the information that is important to your voting decisions at the 2025 Annual Meeting. The Proxy Statement contains other important additional information. We encourage you to carefully read this Supplement together with the Proxy Statement in their entirety. THE PROXY STATEMENT CONTAINS IMPORTANT INFORMATION, AND THIS SUPPLEMENT SHOULD BE READ IN CONJUNCTION WITH THE PROXY STATEMENT. This Supplement updates, and to the extent inconsistent therewith, supersedes, the disclosure in the Proxy Statement to reflect that the New York Stock Exchange ("NYSE") informed the Company of its determination that Proposal 4 of the Proxy Statement, which seeks stockholder approval of an amendment to the Company’s Articles of Amendment and Restatement to increase the number of authorized shares of common stock, is a "routine" matter eligible for discretionary voting by brokers and other nominees under the NYSE rules. Pursuant to the NYSE rules, if you hold your shares through a broker or other nominee and do not instruct such broker or other nominee on how to vote your shares, your broker or other nominee is permit